Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Non-Current Liabilities ₹12 Cr₹10.00 Cr₹8.66 Cr₹7.76 Cr₹7.73 Cr

What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹12 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹12 Cr
Mar2024₹10.00 Cr
Mar2023₹8.66 Cr
Mar2022₹7.76 Cr
Mar2017₹7.73 Cr

How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹12 Cr
18.16
Mar2024 ₹10.00 Cr
15.49
Mar2023 ₹8.66 Cr
11.53
Mar2022 ₹7.76 Cr
0.36
Mar2017 ₹7.73 Cr -

Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,273.7 Cr 4.2% -3.1% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.2%

-3.1%

-26.1%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses